Physician profile
Bruce Bruskoff
NPI 1386622470
$300.82
in general payments reported to CMS, 2019-2025
12 companies · $17.68 in 2025
The $17.68 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $43.02 · 2022: $21.67 · 2023: $21.61 · 2024: $19.32 · 2025: $17.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $40.95 | 2019 | |
| Abbott Laboratories | $40.93 | 2023-2024 | Proclaim |
| Kerecis Limited | $34.20 | 2020-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Horizon Therapeutics Plc | $27.54 | 2019 | |
| Liberty Surgical INC. | $26.50 | 2020 | |
| Zyla Life Sciences, INC. | $24.17 | 2019 | |
| Biotissue Holdings INC. | $21.67 | 2022 | |
| Fidia Pharma USA INC. | $19.09 | 2019 | |
| Sandoz INC. | $18.57 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.16 | 2019 | |
| Celgene Corporation | $15.05 | 2019 | |
| Abbvie INC. | $13.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Bruskoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.